Industry Overview of Pharmaceutical Continuous Manufacturing Market
Pharmaceutical continuous manufacturing is an approach to the production of drugs in the pharmaceutical industry. It enables the uninterrupted flow of materials and production, which increases efficiency and reduces costs. It allows raw materials to continuously undergo various transformations to form a final drug product without the need for intermediate storage or manual intervention. As it assists in streamlining the manufacturing process, improving quality control, enhancing product uniformity, and shorter production cycles while reducing waste generation, the demand for pharmaceutical continuous manufacturing is rising across the globe.
How Big Is the Pharmaceutical Continuous Manufacturing Market?
The global pharmaceutical continuous manufacturing market size reached a value of US$ 1.2 Billion in 2022. It is projected to reach a value of US$ 2.3 Billion by 2028, exhibiting a CAGR of 11.6% during 2023-2028.
Pharmaceutical Continuous Manufacturing Market Trends and Drivers:
At present, the increasing focus on developing personalized medicines and complex drug formulations represents one of the major factors contributing to the growth of the market. Moreover, the growing adoption of continuous manufacturing solutions due to the escalating demand for increased efficiency and productivity in drug manufacturing processes is offering a positive market outlook. Apart from this, the rising employment of pharmaceutical continuous manufacturing, as it enables real-time monitoring and control of critical processes while reducing the risk of deviations, is offering lucrative growth opportunities to industry investors. In addition, the increasing adoption of continuous manufacturing to optimize production and minimize downtime is bolstering the growth of the market. Furthermore, the rising focus on quality assurance and regulatory compliance is strengthening the growth of the market.
What Is Included in Market Segmentation?
The report has segmented the market into the following categories:
Breakup by Therapeutics Type:
- Large Molecules
- Small Molecules
Breakup by Formulation:
- Solid Formulation
- Liquid and Semi-solid Formulation
Breakup by Application:
- Final Drug Product Manufacturing
- API Manufacturing
Breakup by End User:
- Pharmaceutical Companies
- Contract Manufacturing Organizations
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Who Are the Key Players Operating In The Industry?
Top Key Players covered in this report are: Baker Perkins, Coperion GmbH (Hillenbrand Inc.), Eli Lilly and Company, GEA Group Aktiengesellschaft, Glatt GmbH, Korsch AG, Novartis AG, Siemens, SK biotek, Thermo Fisher Scientific Inc. and Viatris Inc.
